Chemoresistance remains one of the most formidable challenges in effective cancer treatment, often leading to disease relapse, metastasis, and poor patient ...

Relative to existing gene signatures, the STRESS signature better predicted not only whether cells would later develop into full-blown pancreatic cancer, but also predicted the aggressive state of the ...

Colon cancer remains a major global health concern, ranking third among the most diagnosed cancers and the leading cause of ...

Scientists have uncovered a molecular "on–off" switch that helps lung adenocarcinoma—the most common form of lung cancer—grow ...

Many people with cancer experience dramatic loss of muscle and fat tissue. In many cases, even the heart muscle is affected, which further weakens the body.

With few treatments available to treat Alzheimer’s disease, scientists have turned to cancer drugs as a potential means of walking back cognitive decline.

Scientists at UCSF and Gladstone Institutes have identified cancer drugs that promise to reverse the changes that occur in ...

Researchers at the University of Oxford and Nanyang Technological University, Singapore (NTU Singapore) have uncovered the mechanism by which cells identify and repair a highly toxic form of DNA ...

Esophageal squamous cell carcinoma (ESCC) is a deadly cancer with particularly high prevalence in East Asia. While ...

A new drug was shown to significantly reduce tumor growth in lab studies by up to 77% for melanoma and colorectal cancers.

AbstractTo explore how early cancers can be detected prior to clinical signs or symptoms, we assessed prospectively collected serial plasma samples from the Atherosclerosis Risk in Communities study, ...

In colorectal cancer, MESA’s diversity metrics outperformed established subtypes at predicting patient survival, whereas in hepatocellular carcinoma, multiomic integration identified significantly ...